Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Qualitative evaluation of survey questions to assess treatment preference for daily oral or long‑acting injectable antiretroviral therapy among people living with HIV.
Journal: PloS one
Published: January 05, 2024
Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial.
Journal: The lancet. HIV
Published: December 20, 2022
Efavirenz-Induced Vanishing Bile Duct Syndrome: A Case Report.
Journal: Journal of pharmacy practice
Published: August 28, 2019
Doravirine dose selection and 96-week safety and efficacy versus efavirenz in antiretroviral therapy-naive adults with HIV-1 infection in a Phase IIb trial.
Journal: Antiviral therapy
Published: May 24, 2019
Kaposi Sarcoma Inflammatory Cytokine Syndrome Presenting as Infection: A Case Report.
Journal: The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons
Published: April 24, 2019
Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide.
Journal: AIDS (London, England)
Published: May 26, 2018
Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks.
Journal: HIV/AIDS (Auckland, N.Z.)
Published: April 21, 2017
Bictegravir versus dolutegravir, each with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: a randomised, double-blind, phase 2 trial.
Journal: The lancet. HIV
Published: December 19, 2016
Outpatient treatment of osteomyelitis with telavancin.
Journal: International journal of antimicrobial agents
Published: August 02, 2016
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.
Journal: The New England journal of medicine
Published: July 22, 2015
Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patients.
Journal: Journal of the International AIDS Society
Published: November 14, 2014
Cryptogenic organizing pneumonia during adjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX) for colon cancer.
Journal: Journal of pharmacy practice
Published: July 31, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026